Skip to main content

Table 2 Rescue antiemetic administration

From: Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial

Postoperative time (h)

Group P (n = 47)

Group A (n = 46)

0−2

10

5

2−6

4

7

6−24

1

2

24−48

0

0

Total incidence

15

14

Total patients

13

13

  1. The data represent the number of patients. Group P was given 0.075 mg of palonosetron intravenously, whereas group A was given 40 mg of oral aprepitant. The total number of patients excludes the number of patients with repeated administration (2 patients in the palonosetron group and 1 patient in the aprepitant group). No significant differences were observed between groups P and A.
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us